{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:25:23Z","timestamp":1783070723918,"version":"3.54.6"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0850-2","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T08:17:03Z","timestamp":1534321023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["European Reference Network For Rare Vascular Diseases (VASCERN) Outcome Measures For Hereditary Haemorrhagic Telangiectasia (HHT)"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9007-5775","authenticated-orcid":false,"given":"Claire L.","family":"Shovlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Buscarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette D.","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Jurgen","family":"Mager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sabba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freya","family":"Droege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Geisthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dupuis-Girod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"issue":"1","key":"850_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-weber syndrome). Am J Med Genet. 2000;91(1):66\u20137.","journal-title":"Am J Med Genet"},{"issue":"1","key":"850_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2307\/1533331","volume":"44","author":"A Bideau","year":"1989","unstructured":"Bideau A, Plauchu H, Brunet G, Robert J. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Population. 1989;44(1):3\u201322.","journal-title":"Population"},{"key":"850_CR3","doi-asserted-by":"crossref","unstructured":"Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999;245(1):31\u20139.","DOI":"10.1046\/j.1365-2796.1999.00398.x"},{"issue":"2","key":"850_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thoraxjnl-2013-203720","volume":"69","author":"JW Donaldson","year":"2014","unstructured":"Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. The UK prevalence of hereditary haemorrhagic telangiectasia and its association with sex, socioeconomic status and region of residence: a population-based study. Thorax. 2014;69(2):161\u20137.","journal-title":"Thorax"},{"issue":"5","key":"850_CR5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/qjmed\/hcl037","volume":"99","author":"C Sabb\u00e0","year":"2006","unstructured":"Sabb\u00e0 C, Pasculli G, Suppressa P, D'Ovidio F, Lenato GM, Resta F, Assennato G, Guanti G. Life expectancy in patients with hereditary haemorrhagic telangiectasia. QJM. 2006;99(5):327\u201334.","journal-title":"QJM"},{"key":"850_CR6","doi-asserted-by":"crossref","unstructured":"Donaldson JW, McKeever TM, Hall IP, Hubbard RB, Fogarty AW. Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study. Neurology. 2015;84(18):1886\u201393.","DOI":"10.1212\/WNL.0000000000001538"},{"key":"850_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13023-016-0427-x","volume":"11","author":"EM de Gussem","year":"2016","unstructured":"de Gussem EM, Edwards CP, Hosman AE, Westermann CJ, Snijder RJ, Faughnan ME, Mager JJ. Life expextancy of parents with hereditary Haemorrhagic telangiectasia. Orphanet J Rare Dis. 2016;11:46.","journal-title":"Orphanet J Rare Dis."},{"key":"850_CR8","doi-asserted-by":"crossref","unstructured":"Kjeldsen A, Aagaard KS, T\u00f8rring PM, M\u00f6ller S, Green A. 20-year follow-up study of Danish HHT patients-survival and causes of death. Orphanet J Rare Dis. 2016;11(1):157.","DOI":"10.1186\/s13023-016-0533-9"},{"issue":"3","key":"850_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1136\/thx.2007.087452","volume":"63","author":"CL Shovlin","year":"2008","unstructured":"Shovlin CL, Jackson JE, Bamford KB, Jenkins IH, Benjamin AR, Ramadan H, Kulinskaya E. Primary determinants of ischaemic stroke\/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax. 2008;63(3):259\u201366.","journal-title":"Thorax"},{"issue":"9","key":"850_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/j.1471-0528.2008.01786.x","volume":"115","author":"CL Shovlin","year":"2008","unstructured":"Shovlin CL, Sodhi V, McCarthy A, Lasjaunias P, Jackson JE, Sheppard MN. Estimates of maternal risks of pregnancy for women with hereditary haemorrhagic telangiectasia (Osler-weber-Rendu syndrome): suggested approach for obstetric services. BJOG. 2008;115(9):1108\u201315.","journal-title":"BJOG"},{"key":"850_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1212\/01.wnl.0000194257.75559.b0","volume":"66","author":"MC Post","year":"2006","unstructured":"Post MC, Thijs V, Schonewille WJ, Budts W, Snijder RJ, Plokker HW, Westermann CJ. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine. Neurology. 2006;66:202\u20135.","journal-title":"Neurology"},{"issue":"4","key":"850_CR12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/lary.20818","volume":"120","author":"JB Hoag","year":"2010","unstructured":"Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010;120(4):838\u201343.","journal-title":"Laryngoscope"},{"issue":"9","key":"850_CR13","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1111\/jth.12654","volume":"12","author":"S Gaillard","year":"2014","unstructured":"Gaillard S, Dupuis-Girod S, Boutitie F, Rivi\u00e8re S, Morini\u00e8re S, Hatron PY, Manfredi G, Kaminsky P, Capitaine AL, Roy P, Gueyffier F, Plauchu H. ATERO study group. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross-over controlled trial in a rare disease. J Thromb Haemost. 2014;12(9):1494\u2013502.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"850_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/lary.20065","volume":"119","author":"E Yaniv","year":"2009","unstructured":"Yaniv E, Preis M, Hadar T, Shvero J, Haddad M. Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a double-blind placebo-controlled clinical trial. Laryngoscope. 2009;119(2):284\u20138.","journal-title":"Laryngoscope"},{"issue":"2","key":"850_CR15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4193\/Rhin16.315","volume":"55","author":"VJ Lund","year":"2017","unstructured":"Lund VJ, Darby Y, Rimmer J, Amin M, Husain S. Nasal closure for severe hereditary haemorrhagic telangiectasia in 100 patients. The Lund modification of the Young's procedure: a 22-year experience. Rhinology. 2017;55(2):135\u201341.","journal-title":"Rhinology"},{"key":"850_CR16","doi-asserted-by":"crossref","unstructured":"Shovlin CL, Patel T, Jackson JE. Embolisation of PAVMs reported to improve nosebleeds by a subgroup of patients with hereditary haemorrhagic telangiectasia. ERJ Open Res. 2016;2(2). eCollection 2016 Apr. PMID:27730189.","DOI":"10.1183\/23120541.00035-2016"},{"issue":"5","key":"850_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/lary.23893","volume":"123","author":"BM Silva","year":"2013","unstructured":"Silva BM, Hosman AE, Devlin HL, Shovlin CL. Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia. Laryngoscope. 2013;123(5):1092\u20139.","journal-title":"Laryngoscope"},{"key":"850_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73\u201387.","journal-title":"J Med Genet"},{"issue":"12","key":"850_CR19","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1136\/thoraxjnl-2017-210764","volume":"72","author":"CL Shovlin","year":"2017","unstructured":"Shovlin CL, Condliffe R, Donaldson JW, Kiely DG, Wort SJ, British Thoracic Society. British Thoracic Society Clinical Statement on Pulmonary Arteriovenous Malformations. Thorax. 2017;72(12):1154\u201363.","journal-title":"Thorax"},{"issue":"9917","key":"850_CR20","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(13)62302-8","volume":"383","author":"JP Mohr","year":"2014","unstructured":"Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, Al-Shahi Salman R, Vicaut E, Young WL, Houdart E, Cordonnier C, Stefani MA, Hartmann A, von Kummer R, Biondi A, Berkefeld J, Klijn CJ, Harkness K, Libman R, Barreau X, Moskowitz AJ, International ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet. 2014;383(9917):614\u201321.","journal-title":"Lancet"},{"issue":"1","key":"850_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","volume":"64","author":"European Association for the Study of the Liver","year":"2016","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: vascular diseases of the liver. J Hepatol. 2016;64(1):179\u2013202.","journal-title":"J Hepatol"},{"key":"850_CR22","unstructured":"European Reference Networks: \n                    https:\/\/ec.europa.eu\/health\/ern_en\n                    \n                  . Accessed 09 Feb 2018."},{"key":"850_CR23","unstructured":"The European Reference Network for Vascular Diseases (VASCERN) HHT WG: \n                    https:\/\/vascern.eu\/expertise\/rare-diseases-wgs\/hht-wg\/\n                    \n                   Accessed 09 Feb 2018."},{"issue":"3","key":"850_CR24","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/ane.12167","volume":"129","author":"AD Kjeldsen","year":"2014","unstructured":"Kjeldsen AD, T\u00f8rring PM, Nissen H, Andersen PE. Cerebral abscesses among Danish patients with hereditary haemorrhagic telangiectasia. Acta Neurol Scand. 2014;129(3):192\u20137.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"850_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.clineuro.2011.10.036","volume":"114","author":"S Mathis","year":"2012","unstructured":"Mathis S, Dupuis-Girod S, Plauchu H, Giroud M, Barroso B, Ly KH, Ingrand P, Gilbert B, Goden\u00e8che G, Neau JP. Cerebral abscesses in hereditary haemorrhagic telangiectasia: a clinical and microbiological evaluation. Clin Neurol Neurosurg. 2012;114(3):235\u201340.","journal-title":"Clin Neurol Neurosurg"},{"key":"850_CR26","doi-asserted-by":"publisher","unstructured":"Boother EJ, Brownlow S, Tighe HC, Bamford KB, Jackson JE, Shovlin CL. Cerebral abscess associated with odontogenic bacteremias, hypoxemia, and iron loading in immunocompetent patients with right-to-left shunting through pulmonary arteriovenous malformations. Clin Infect Dis. 2017; \n                    https:\/\/doi.org\/10.1093\/cid\/cix373\n                    \n                  .","DOI":"10.1093\/cid\/cix373"},{"key":"850_CR27","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.diii.2013.03.014","volume":"94","author":"P Lacombe","year":"2013","unstructured":"Lacombe P, Lacout A, Marcy PY, Binsse S, Sellier J, Bensalah M, Chinet T, Bourgault-Villada I, Blivet S, Roume J, et al. Diagnosis and treatment of pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: an overview. Diagn Interv Imaging. 2013;94:835\u201348.","journal-title":"Diagn Interv Imaging"},{"key":"850_CR28","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1148\/radiol.13122153","volume":"269","author":"CS Woodward","year":"2013","unstructured":"Woodward CS, Pyeritz RE, Chittams JL, Trerotola SO. Treated pulmonary arteriovenous malformations: patterns of persistence and associated retreatment success. Radiology. 2013;269:919\u201326.","journal-title":"Radiology"},{"key":"850_CR29","unstructured":"NICE Clinical Knowledge Summaries (CKS):Treating iron deficiency anemia Available \n                    https:\/\/cks.nice.org.uk\/anaemia-iron-deficiency#!scenariorecommendation\n                    \n                   Accessed 09 Feb 2018."},{"key":"850_CR30","unstructured":"Iron Deficiency Anaemia. Assessment, Prevention, and control a guide for programme managers. World Health Organisation 2001. \n                    http:\/\/www.who.int\/nutrition\/publications\/micronutrients\/anaemia_iron_deficiency\/WHO_NHD_01.3\/en\/\n                    \n                  . Accessed 09 Feb 2018."},{"issue":"6","key":"850_CR31","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1513\/AnnalsATS.201611-872OC","volume":"14","author":"A Rizvi","year":"2017","unstructured":"Rizvi A, Macedo P, Babawale L, Tighe HC, Hughes JMB, Jackson JE, Shovlin CL. Hemoglobin is a vital determinant of arterial oxygen content in hypoxemic patients with pulmonary arteriovenous malformations. Ann Am Thorac Soc. 2017;14(6):903\u201311.","journal-title":"Ann Am Thorac Soc"},{"issue":"7","key":"850_CR32","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/jac\/dkw081","volume":"71","author":"J Limeres Posse","year":"2016","unstructured":"Limeres Posse J, \u00c1lvarez Fern\u00e1ndez M, Fern\u00e1ndez Feijoo J, Medina Henr\u00edquez J, Lockhart PB, Chu VH, Diz Dios P. Intravenous amoxicillin\/clavulanate for the prevention of bacteraemia following dental procedures: a randomized clinical trial. J Antimicrob Chemother. 2016;71(7):2022\u201330.","journal-title":"J Antimicrob Chemother"},{"key":"850_CR33","doi-asserted-by":"crossref","unstructured":"Nakayama M, Nawa T, Chonan T, Endo K, Morikawa S, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med. 2012;51:1677\u201381.","DOI":"10.2169\/internalmedicine.51.7305"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0850-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0850-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0850-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T19:18:26Z","timestamp":1565810306000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0850-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["850"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0850-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"12 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CLS is the Chair, SDG is the CoChair and EB the Deputy CoChair of VASCERN HHT. The Outcome measures were developed by the HHT WG between March and June 2016. The discussion text was developed during monthly telecons, face to face meeting and by email October 2017\u2013February 2018.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"136"}}